ALMATICA PHARMA LLC – Trademark Portfolio

Entity Type: 16

ALMATICA PHARMA LLC holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 16 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 4 trademarks are registered and 4 are pending. Notable registered marks include GRALISE and LOREEV XR. The owner is based in MORRISTOWN, NJ.

44 WHIPPANY ROAD, SUITE 300

MORRISTOWN, NJ 07960

17 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

ALMATICA PHARMA LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (16 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does ALMATICA PHARMA LLC have?

ALMATICA PHARMA LLC has 17 U.S. trademarks filed with the USPTO. Of these, 4 registered, 4 pending, 9 abandoned.

What trademark classes does ALMATICA PHARMA LLC file in?

ALMATICA PHARMA LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are ALMATICA PHARMA LLC's most well-known trademarks?

ALMATICA PHARMA LLC's registered trademark portfolio includes well-known marks such as GRALISE and LOREEV XR. These are among 4 currently registered trademarks in the portfolio.

What is ALMATICA PHARMA LLC's trademark registration success rate?

ALMATICA PHARMA LLC has a 31% trademark registration rate, with 4 out of 13 resolved applications resulting in successful registration. Currently, 4 applications are pending review.